ABSI Net Margin
-7756.37%TTM
Period ending:
ABSI FY Net Margin%
157.34%-4571.29%
2019-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
ABSI net margin history
Net income as a percentage of revenue. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.
| Period ending | Net Margin |
|---|---|
| -4,113.6786% | |
| -2,274.0626% | |
| -1,933.6481% | |
| -1,825.3698% | |
| -2,111.2505% | |
| -300.272% | |
| -319.6117% |
Compare net margin
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) net margin
- Bridgebio Pharma Inc (BBIO) net margin
- Brightspring Health Services Inc (BTSG) net margin
- Madrigal Pharmaceuticals Inc (MDGL) net margin
- Ensign Group Inc (ENSG) net margin
- Glaukos Corp (GKOS) net margin
- Krystal Biotech Inc (KRYS) net margin
- Twist Bioscience Corp (TWST) net margin
Compare all covered stocks by net margin →
All ABSI financial metrics · ABSI stock overview · How to interpret financial metrics
